A fused gene of nucleoprotein (NIP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus

被引:50
作者
Saha, Sukumar [1 ]
Yoshida, Shinsuke [1 ]
Ohba, Kenji [1 ]
Matsui, Kiyohiko [1 ]
Matsuda, Tomoko [1 ]
Takeshita, Fumihiko [1 ]
Umeda, Kazunori [1 ]
Tamura, Yuichi [1 ]
Okuda, Kentaro [3 ]
Klinman, Dennis [2 ]
Xin, Ke-Qin [1 ]
Okuda, Kenji [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Mol Biodef Res, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan
[2] US FDA, CBER, Bethesda, MD 20892 USA
[3] Kyushu Univ, Fac Med Sci, Dept Oral Hlth Technol & Epidemiol, Fukuoka 81285822, Japan
关键词
influenza nucleoprotein (NP); herpes simplex virus gene protein 22 (VP22); DNA vaccine; A/PR/8/34; HSV-1; CD8(+) cells; CD4(+) cells; intercellular spreading;
D O I
10.1016/j.virol.2006.04.015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We evaluated the immunogenicity and protective activity of plasmid DNA vaccines encoding the influenza virus NP gene (pNP) alone or in combination with the herpes simplex virus type 1 protein 22 gene (pVP22). Optimal immune responses were observed in BALB/c mice immunized with the combination of pVP22 plus pNP, as assessed by enzyme-linked immunosorbent assay (ELISA), enzyme-linked immunospot (ELISPOT) and intracellular cytokine staining (ICCS). These mice also showed maximal resistance following challenge with the A/PR/8/34 (H1N1) and A/Udron/72 (H3N2) strains of influenza virus. The susceptibility of immunized mice to virus infection was significantly increased following depletion of either CD4(+) or CD8(+) T cells. These results indicate that a plasmid DNA vaccine encoding pVP22 plus NP induces a high level of cross-protective immunity against influenza virus subtypes. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 43 条
[31]   Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery [J].
Pertmer, TM ;
Roberts, TR ;
Haynes, JR .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6119-6125
[32]   Intercellular delivery of functional p53 by the herpesvirus protein VP22 [J].
Phelan, A ;
Elliott, G ;
O'Hare, P .
NATURE BIOTECHNOLOGY, 1998, 16 (05) :440-443
[33]  
ROBINSON HL, 1997, J INFECT DIS S1, V176, P50
[34]  
SARMIENTO M, 1980, J IMMUNOL, V125, P2665
[35]   Specific inhibition of transcription factor NF-κB through intracellular protein delivery of IκBα by the Herpes virus protein VP22 [J].
Stroh, C ;
Held, E ;
Samraj, AK ;
Schulze-Osthoff, K .
ONCOGENE, 2003, 22 (34) :5367-5373
[36]   PROTECTIVE IMMUNITY BY INTRAMUSCULAR INJECTION OF LOW-DOSES OF INFLUENZA-VIRUS DNA VACCINES [J].
ULMER, JB ;
DECK, RR ;
DEWITT, CM ;
FRIEDMAN, A ;
DONNELLY, JJ ;
LIU, MA .
VACCINE, 1994, 12 (16) :1541-1544
[37]   Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity [J].
Ulmer, JB ;
Deck, RR ;
DeWitt, CM ;
Fu, TM ;
Donnelly, JJ ;
Caulfield, MJ ;
Liu, MA .
VACCINE, 1997, 15 (08) :839-841
[38]   Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA [J].
Ulmer, JB ;
Fu, TM ;
Deck, RR ;
Friedman, A ;
Guan, LM ;
DeWitt, C ;
Liu, X ;
Wang, S ;
Liu, MA ;
Donnelly, JJ ;
Caulfield, MJ .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5648-5653
[39]   Nuclear trafficking of influenza virus ribonucleoproteins in heterokaryons [J].
Whittaker, G ;
Bui, M ;
Helenius, A .
JOURNAL OF VIROLOGY, 1996, 70 (05) :2743-2756
[40]   Increased DNA vaccine delivery and immunogenicity by electroporation in vivo [J].
Widera, G ;
Austin, M ;
Rabussay, D ;
Goldbeck, C ;
Barnett, SW ;
Chen, MC ;
Leung, L ;
Otten, GR ;
Thudium, K ;
Selby, MJ ;
Ulmer, JB .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4635-4640